Department of Molecular Biology, Institute of Endemic Diseases, University of Khartoum, P. O. Box 102, Army Road, 11111, Khartoum, Sudan.
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
BMC Genomics. 2018 Jan 15;19(1):46. doi: 10.1186/s12864-018-4433-3.
The conventional variant calling of pathogenic alleles in exome and genome sequencing requires the presence of the non-pathogenic alleles as genome references. This hinders the correct identification of variants with minor and/or pathogenic reference alleles warranting additional approaches for variant calling.
More than 26,000 Exome Aggregation Consortium (ExAC) variants have a minor reference allele including variants with known ClinVar disease alleles. For instance, in a number of variants related to clotting disorders, the phenotype-associated allele is a human genome reference allele (rs6025, rs6003, rs1799983, and rs2227564 using the assembly hg19). We highlighted how the current variant calling standards miss homozygous reference disease variants in these sites and provided a bioinformatic panel that can be used to screen these variants using commonly available variant callers. We present exome sequencing results from an individual with venous thrombosis to emphasize how pathogenic alleles in clinically relevant variants escape variant calling while non-pathogenic alleles are detected.
This article highlights the importance of specialized variant calling strategies in clinical variants with minor reference alleles especially in the context of personal genomes and exomes. We provide here a simple strategy to screen potential disease-causing variants when present in homozygous reference state.
外显子组和基因组测序中致病等位基因的常规变异调用需要存在非致病等位基因作为基因组参考。这阻碍了对具有次要和/或致病参考等位基因的变体的正确识别,需要额外的变体调用方法。
超过 26,000 个外显子组聚合联盟 (ExAC) 变体具有次要参考等位基因,包括具有已知 ClinVar 疾病等位基因的变体。例如,在与凝血障碍相关的许多变体中,表型相关的等位基因是人类基因组参考等位基因(使用 hg19 组装的 rs6025、rs6003、rs1799983 和 rs2227564)。我们强调了当前的变异调用标准如何在这些位点错过纯合参考疾病变体,并提供了一个生物信息学面板,可用于使用常用的变异调用器筛选这些变体。我们展示了个体静脉血栓形成的外显子组测序结果,以强调在临床相关变体中具有次要参考等位基因的致病等位基因如何逃避变异调用,而同时检测到非致病等位基因。
本文强调了在具有次要参考等位基因的临床变体中使用专门的变异调用策略的重要性,尤其是在个人基因组和外显子组的背景下。我们在此提供了一种简单的策略,用于在纯合参考状态下存在时筛选潜在的致病变体。